Blood Transfusion Diagnostics Market to reach US$ 8.7 Billion by 2032; Blood Grouping to expand at a 5.8% CAGR: Fact.MR
07 déc. 2022 14h00 HE
|
FACT.MR
Rockville, Dec. 07, 2022 (GLOBE NEWSWIRE) -- According to a recent report by Fact.MR, a market research and competitive intelligence provider, market of blood transfusion diagnostics is predicted to...
Quotient Limited Announces CFO Transition
02 nov. 2016 16h15 HE
|
Quotient Limited
JERSEY, Channel Islands, Nov. 02, 2016 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, announced today that the company and Stephen Unger, Chief Financial...
Quotient Limited Reports Continued Progress on the Commercial Scale-up of MosaiQ™ and Second Quarter Fiscal 2017 Financial Results
31 oct. 2016 16h15 HE
|
Quotient Limited
JERSEY, Channel Islands, Oct. 31, 2016 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today reported further progress on the commercial scale-up of...
Quotient Limited Announces Booth Tour at the 2016 AABB Annual Meeting and Provides Update of Expected Timing of Internal Evaluation Study Results
21 oct. 2016 08h30 HE
|
Quotient Limited
JERSEY, Channel Islands, Oct. 21, 2016 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that the Company’s executive management team will...
Quotient Limited to Report Second Quarter Fiscal 2017 Financial Results and Host Conference Call
17 oct. 2016 08h30 HE
|
Quotient Limited
JERSEY, Channel Islands, Oct. 17, 2016 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that financial results for its fiscal...
Quotient Limited Announces $120 Million Secured Debt Financing
14 oct. 2016 16h01 HE
|
Quotient Limited
JERSEY, Channel Islands, Oct. 14, 2016 (GLOBE NEWSWIRE) -- Quotient Limited (“Quotient”) (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced the completion of a private...
Quotient Limited Announces Successful Validation of the Initial Manufacturing System for MosaiQ™ Microarrays
08 sept. 2016 16h05 HE
|
Quotient Limited
MosaiQTM manufacturing system operating in accordance with design requirements Ongoing evaluation of MosaiQTM methodology continues to demonstrate concordance levels in excess of 99.0% for key blood...
Quotient Limited Reports Further Progress on the Commercial Scale-up of MosaiQ™ and First Quarter Fiscal 2017 Financial Results
08 août 2016 16h15 HE
|
Quotient Limited
Facility modification completed – humidity control successfully resolved issue previously impacting final assembly of MosaiQ™ consumablesValidation of the initial manufacturing system for MosaiQ™...
Quotient Limited Announces Closing of Underwritten Offering of Ordinary Shares
03 août 2016 16h05 HE
|
Quotient Limited
JERSEY, Channel Islands, Aug. 03, 2016 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced the closing of its underwritten public offering...
Quotient Limited to Report First Quarter Fiscal 2017 Financial Results and Host Conference Call
01 août 2016 08h30 HE
|
Quotient Limited
JERSEY, Channel Islands, Aug. 01, 2016 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that financial results for its fiscal first...